Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers have developed a machine learning algorithm that could improve clinicians’ ability to identify hospitalised patients who need intensive care.

Hospital room

The HAVEN system was developed as part of a collaboration between the University of Oxford’s Institute of Biomedical Engineering and the Nuffield Department of Clinical Neurosciences (NDCN), with support from the NIHR Oxford Biomedical Research Centre.

The findings of the study have been published in the American Journal of Respiratory and Critical Care Medicine.

'The HAVEN machine learning algorithm, using electronic patient data collected routinely by most NHS hospitals, has the potential to substantially improve our ability to detect patients who require ICU, and those for whom a timely intervention is likely to change their outcome, so enhancing the National Early Warning Score (NEWS) system currently in use across the health service,' said Professor Peter Watkinson, Associate Professor of Intensive Care Medicine at NDCN.

The HAVEN (Hospital-wide Alerting Via Electronic Noticeboard) system combines patients’ vital signs - such as blood pressure, heart rate and temperature - with their blood test results, comorbidities and frailty into a single risk score. The HAVEN score gives a more precise indication of which patients are deteriorating when compared with previously published scores.

Read the full story on the Nuffield Department of Clinical Neurosciences website

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.